We found that CADASIL patients with an EGFr domain 1–6 PV had a 12-year-earlier age at onset of stroke, lower survival time and greater brain MRI lesion load than patients with an EGFr domain 7–34 PV. The gene discussed is EGFR; the disease is stroke disorder.